Enhance Genetics Body Building
New posts
Install the app
How to install the app on iOS

Follow along with the video below to see how to install our site as a web app on your home screen.

Note: This feature may not be available in some browsers.


Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with

E

EGBOT

Guest
Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

HTML: 
Pharmacyclics LLC today announced interim results from the ongoing Phase Ib/II PCYC-1129 study suggesting that ibrutinib (IMBRUVICA) may be a safe and effective treatment for patients with chronic graft-versus-host-disease (cGVHD) who were either refractory to steroid treatment or were steroid-dependent.

Source: Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Register

Log in

Already have an account? Log in here.

Similar threads

EG News
Bimagrumab May Be The Future of Weight-Loss Treatment
Weight-loss medications such as Ozempic have proven to significantly drop fat in patients, but experts have also warned of the accompanying muscle...
Replies
0
Views
62
EG News
EG News
EG News
Steroid dosage risks and benefits when managing lupus nephritis
A recent Mayo Clinic study highlights the link between glucocorticoid dosage and outcomes in patients with lupus nephritis, a type of kidney...
Replies
0
Views
210
EG News
EG News
EG News
The Right Way to Use GLP-1 Drugs to Lose Fat and Keep Muscle
Recent studies have raised alarms about GLP-1 drugs, like Ozempic, Wegovy, and Mounjaro, highlighting that a significant portion of the weight...
Replies
0
Views
102
EG News
EG News

Latest threads

Back
Top